A novel approach to removing excess fluid through the skin and a new strategy to prevent right ventricular failure after LVAD ...

New long-term data showed that the VenusP-valve delivered durable outcomes in patients undergoing percutaneous pulmonary ...

Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer baseAdvance SeaStar Medical’s ...

Patients who developed late right heart failure (RHF) after left ventricular assist device (LVAD) surgery suffered more major adverse events and had worse survival, researchers found. At 1 month ...

Background Long-term success in ventricular assist device (VAD) recipients is limited by thromboembolic events, the prediction of which remains elusive. We evaluated the predictive value of aspirin ...

Kodiak Solutions has hired Victoria Dames to lead product development as Kodiak continues to build out its next-generation platform serving healthcare finance and revenue cycle departments. "Victoria ...

Trinity Health Ann Arbor has completed Michigan’s first implant of the world’s smallest device designed to help treat ...

Fort Wayne’s opioid settlement payments are scheduled to run through 2038. The local National Opioid Settlement Committee ...

A tiny leadless pacemaker implanted at Netcare Unitas Hospital marks a significant step in treating heart rhythm disorders.

EBR Systems (ASX:EBR) gained FDA approval for WiSE in April 2025 and it is the world’s only wireless endocardial (placed ...

Better devices and changes in implant depth have likely led to fewer LBBBs over time, but the issue needs continued attention ...

Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.